A Comprehensive Evaluation of Hyperbaric Oxygen Therapy in Resuscitation Medicine - a Pilot Study (HOT-RESUS 1 Trial)
HOT-RESUS 1
1 other identifier
interventional
45
1 country
1
Brief Summary
In this prospective pilot study, the effects of hyperbaric oxygen therapy (HBOT) in post-cardiac arrest syndrome will be evaluated. However, the primary outcome of this pilot study will be the feasibility of this approach. If feasibility is determined, a larger study with adequate powering is to follow.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2022
CompletedFirst Posted
Study publicly available on registry
December 12, 2022
CompletedStudy Start
First participant enrolled
February 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedDecember 13, 2024
December 1, 2024
11 months
November 22, 2022
December 9, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility of the study approach
Successfully recruiting at least 10 patients in each of the 3 study arms
8 months
Secondary Outcomes (1)
Inflammation dynamics
around 7 days (individual patient) / 8 months (study duration)
Study Arms (3)
post-ROSC
EXPERIMENTALpatients directly post-ROSC receiving HBOT
cardiac arrest survivors discharged home receiving HBOT
ACTIVE COMPARATORcardiac arrest survivors discharged home
healthy volunteers receiving HBOT
ACTIVE COMPARATORhealthy volunteers receiving HBOT
Interventions
Hyperbaric oxygen therapy in a pressurized chamber, duration 1-2 hours at 2-3 ATA
Eligibility Criteria
You may not qualify if:
- Healthy volunteers:
- CA survivors after hospital discharge:
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Antwerplead
- Medical University of Viennacollaborator
Study Sites (1)
Antwerp University Hospital
Edegem, 2650, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Koen Monsieurs, Prof., MD
University Hospital of Antwerp, Belgium
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Koen Monsieurs, MD
Study Record Dates
First Submitted
November 22, 2022
First Posted
December 12, 2022
Study Start
February 1, 2023
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
December 13, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share